Ligand Pharmaceuticals
LGND
#3595
Rank
NZ$6.55 B
Marketcap
NZ$333.16
Share price
1.09%
Change (1 day)
66.47%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): NZ$0.11 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.25 Billion. In 2024 the company made an earning of NZ$9.32 Million a decrease over its 2023 earnings that were of NZ$0.10 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.11 B1084.75%
2024 NZ$9.32 M-91.37%
2023 NZ$0.10 B-7.59%
2022 NZ$0.11 B4%
2021 NZ$0.11 B296.42%
2020 NZ$28.36 M-97.97%
2019 NZ$1.39 B275.62%
2018 NZ$0.37 B237.48%
2017 NZ$0.11 B49.05%
2016 NZ$74.01 M55.41%
2015 NZ$47.62 M36.87%
2014 NZ$34.79 M29.59%
2013 NZ$26.84 M1309.35%
2012 NZ$1.9 M-43.97%
2011 NZ$3.4 M-113.19%
2010 -NZ$25.78 Million59.86%
2009 -NZ$16.13 Million-61.33%
2008 -NZ$41.71 Million-58.75%
2007 -NZ$0.11 Billion20.52%
2006 -NZ$83.89 Million81.27%
2005 -NZ$46.28 Million
2003 -NZ$32.22 Million-20.6%
2002 -NZ$40.58 Million4.38%
2001 -NZ$38.88 Million-48.83%
2000 -NZ$75.96 Million-19.74%
1999 -NZ$94.65 Million-19.06%
1998 -NZ$0.12 Billion126.71%
1997 -NZ$51.58 Million-5.83%
1996 -NZ$54.77 Million136.23%
1995 -NZ$23.19 Million-33.97%
1994 -NZ$35.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$54.42 B 48,402.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$19.91 B 17,644.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$37.80 B 33,591.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$13.84 B 12,242.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-NZ$0.46 Billion-504.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$38.79 B 34,469.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.49 B 11,926.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$15.66 B 13,857.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-NZ$0.11 Billion-192.65%๐Ÿ‡บ๐Ÿ‡ธ USA